Telegram Group Search

🚨 کووید-۱۹ ؛ اخبار و نکات واکسن

1,374 Members
Date:
group-telegram.com/SARScoVTwo
🚨 کووید-۱۹ ؛ اخبار و نکات واکسن
   4.45
34730 Reviews
Posts
33968 Posts


🚨 کووید-۱۹ ؛ اخبار و نکات واکسن Telegram | DID YOU KNOW?

Date: |

In 2018, Russia banned Telegram although it reversed the prohibition two years later. Official government accounts have also spread fake fact checks. An official Twitter account for the Russia diplomatic mission in Geneva shared a fake debunking video claiming without evidence that "Western and Ukrainian media are creating thousands of fake news on Russia every day." The video, which has amassed almost 30,000 views, offered a "how-to" spot misinformation. "And that set off kind of a battle royale for control of the platform that Durov eventually lost," said Nathalie Maréchal of the Washington advocacy group Ranking Digital Rights. In a message on his Telegram channel recently recounting the episode, Durov wrote: "I lost my company and my home, but would do it again – without hesitation." "Your messages about the movement of the enemy through the official chatbot … bring new trophies every day," the government agency tweeted.
🚨 کووید-۱۹ ؛ اخبار و نکات واکسن from us

🚨 کووید-۱۹ ؛ اخبار و نکات واکسندربارۀ کووید-۱۹ و واکسن‌های کووید-۱۹
مرتبط با:
www.group-telegram.com/nouritazeh

این کانال، زمانی آرشیو پیوستهای مطالب
www.group-telegram.com/andishehsarapub
بود، از آغاز شیوع کووید از آن برای آگاهی‌بخشی کمک گرفتیم و پایۀ ایجاد کانالی دربارۀ کووید و واکسن شد.

فقط پیام ضروری:
@pakrouh

🚨 کووید-۱۹ ؛ اخبار و نکات واکسن
group-telegram.com/SARScoVTwo


Open Telegram

Singapore SG telegram Group & telegram Channel 10

Telegram 🚨 کووید-۱۹ ؛ اخبار و نکات واکسن

Created: 2021-02-10

From: Singapore and American

Telegram 🚨 کووید-۱۹ ؛ اخبار و نکات واکسن, 463136 Telegram Group & Telegram Channel Singapore, SG

Telegram 🚨 کووید-۱۹ ؛ اخبار و نکات واکسن, 463136 Telegram Group & Telegram Channel, American, US

TG 🚨 کووید-۱۹ - کوروناویروس

https://t.me/sarscovtwo

Open Telegram

Telegram Group
Back To Top